CASSANDRA BURKS: Open Payments
NPI 1700546223 · RANDALLSTOWN, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$315 in 13 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $486 · 2025 $315
Food & beverage: $315
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 8 | $191 |
| Teva Pharmaceuticals USA, Inc. | 2 | $48 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: Qelbree, UZEDY, INGREZZA, HETLIOZ, SPRAVATO.
Industry payments across MD — which companies pay providers there.
